Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
PuqU96dbnZ1Kepn6
Listen
